Pharmalene B Special Precautions

Ultraviolet Light and Environmental Exposure: Exposure to sunlight should be minimized during the use of Pharmalene B. Use of sunscreen products and protective apparel (e.g. hat ) are recommended when exposure cannot be avoided. Weather extremes, such as wind or cold, may be irritating to patients under treatment with Pharmalene B.
Local Cutaneous Reactions: Erythema, scaling, dryness, and stinging/burning may be experienced with use of Pharmalene B. These are most likely to occur during the first four weeks of treatment, are mostly mild to moderate in intensity, and usually lessen with continued use of the medication. Depending upon the severity of these side effects, patients should be instructed to use a moisturizer, reduce the frequency of the application of Pharmalene B, or discontinued use.
Pharmalene B should not be applied to damaged skin, either broken (cuts or abrasions), eczematous or sunburned. As with other Retinoids, use of waxing as a depilatory method should be avoided on skin treated with Pharmalene B.
Avoid concomitant use of other potentially irritating topical products (medicated or abrasive soaps and cleansers, soaps and cosmetics that have strong skin-drying effect and products with high concentrations of alcohol, astringents, spices, or limes).
This product contains Propylene Glycol that may cause skin irritation.
If a reaction suggesting sensitivity to any component of the formula occurs, the use of Pharmalene B should be discontinued.
Pharmalene B should not come into contact with any coloured material including hair and dyed fabrics as this may result in bleaching and discoloration.
Use in Pregnancy: Pregnancy category C. Pharmalene B should be used during pregnancy only if the potential benefit justifies the risk to the fetus.
Use in Lactation: It is not known whether Adapalene or Benzoyl peroxide is excreted in human milk following use of Pharmalene B. Because many drugs are excreted in human milk, caution should be exercised when Pharmalene B is administered to a nursing woman.
Use in Children: Safety and effectiveness of Pharmalene B in pediatric patients under the age of 12 have not been established.